Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-31

FDA Approved: MESALAMINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the Original Application for Mesalamine from Aurobindo Pharma Limited (generic Mesalamine). Indications include inflammatory bowel diseases such as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)